Menu
Not yet recruiting NCT06642805

Bilio-pancreatic Complications of Congenital Duodenal Obstructions

Observational Duodenal Obstruction

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: duodenal atresia.
Who it may be relevant to
Registry conditions: Duodenal Obstruction. Basic parameters: up to 16 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Congenital duodenal obstructions, often grouped under the term duodenal atresias, encompass a range of malformations of the duodenum that cause partial or complete obstruction. In the long term, the main complications described fall within the spectrum of digestive occlusions (anastomotic stenosis, obstruction due to adhesions, and duodenal dysmotility) and may require surgical revisions. Biliary and pancreatic complications, which are embryologically logical, are reported in the form of rare clinical cases. The aim of the research is to identify biliopancreatic complications following duodenal atresia surgery in order to characterize them, estimate their national frequency, and determine any potential iatrogenic risk factors.

Interventions

  • Procedure duodenal atresia
    surgery for duodenal atresia

Primary outcome measures

  • frequency of biliar complication after surgical treatment of duodenal atresia [Time frame: 1 year]
  • frequency of pancreatic complication after surgical treatment of duodenal atresia [Time frame: 1 year]

Eligibility criteria

Inclusion criteria

  • Patients who underwent surgery for duodenal atresia in a pediatric surgery department participating in the study over the past 20 years,
  • legal representatives did not object to data collection

Exclusion criteria

  • Patients ≥ 16 years at the time of surgery.
  • Objection from the legal representatives of the child or the adult patient to the collection and use of health data

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06642805 · 49RC24_0157

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗